Nagavakishore Pillarsetty

Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71.

S. Larson, Jason S. Lewis, Tony Taldone, 2013 .

Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use

T. Reiner, I. Ganly, Snehal G. Patel, 2022, Molecular Imaging and Biology.

The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer.

P. Kantoff, N. Schultz, M. Morris, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

J. Osborne, S. Tagawa, S. Castellanos, 2022, Translational oncology.

PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.

T. Reiner, J. Bargonetti, G. Xiao, 2021, Molecular pharmaceutics.

Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use

T. Reiner, I. Ganly, H. Schöder, 2022, Molecular Imaging and Biology.

Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe

Jason S. Lewis, Xianzhong Wu, Kelly E. Henry, 2021, Clinical Cancer Research.